Penserra Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6K | Hold |
18
| – | – | ﹤0.01% | 943 |
|
|
2026
Q1 | $5K | Hold |
18
| – | – | ﹤0.01% | 929 |
|
|
2025
Q4 | $6K | Hold |
18
| – | – | ﹤0.01% | 879 |
|
|
2025
Q3 | $5K | Hold |
18
| – | – | ﹤0.01% | 881 |
|
|
2025
Q2 | $7K | Sell |
18
-1,117
| -98% | -$449K | ﹤0.01% | 845 |
|
|
2025
Q1 | $492K | Sell |
1,135
-536
| -32% | -$215K | 0.01% | 596 |
|
|
2024
Q4 | $614K | Buy |
1,671
+562
| +51% | +$235K | 0.01% | 524 |
|
|
2024
Q3 | $576K | Buy |
1,109
+13
| +1% | +$6.95K | 0.01% | 505 |
|
|
2024
Q2 | $594K | Sell |
1,096
-5
| -0.5% | -$2.64K | 0.01% | 551 |
|
|
2024
Q1 | $570K | Sell |
1,101
-1,029
| -48% | -$512K | 0.01% | 555 |
|
|
2023
Q4 | $1M | Sell |
2,130
-426
| -17% | -$197K | 0.02% | 378 |
|
|
2023
Q3 | $1.11M | Sell |
2,556
-155
| -6% | -$70.3K | 0.02% | 337 |
|
|
2023
Q2 | $1.2M | Buy |
2,711
+1,397
| +106% | +$644K | 0.02% | 356 |
|
|
2023
Q1 | $603K | Buy |
1,314
+55
| +4% | +$26.2K | 0.01% | 459 |
|
|
2022
Q4 | $645K | Buy |
1,259
+100
| +9% | +$50.8K | 0.01% | 476 |
|
|
2022
Q3 | $526K | Buy |
1,159
+30
| +3% | +$14.4K | 0.01% | 415 |
|
|
2022
Q2 | $544K | Sell |
1,129
-76
| -6% | -$37.6K | 0.01% | 462 |
|
|
2022
Q1 | $591K | Buy |
1,205
+46
| +4% | +$21K | 0.01% | 474 |
|
|
2021
Q4 | $536K | Buy |
1,159
+196
| +20% | +$82.5K | 0.01% | 522 |
|
|
2021
Q3 | $358K | Buy |
963
+108
| +13% | +$41K | 0.01% | 553 |
|
|
2021
Q2 | $325K | Buy |
855
+222
| +35% | +$84.8K | 0.01% | 560 |
|
|
2021
Q1 | $227K | Buy |
633
+100
| +19% | +$32.2K | ﹤0.01% | 559 |
|
|
2020
Q4 | $171K | Buy |
533
+91
| +21% | +$27.9K | ﹤0.01% | 556 |
|
|
2020
Q3 | $118K | Sell |
442
-7,900
| -95% | -$2.13M | ﹤0.01% | 472 |
|
|
2020
Q2 | $2.19M | Buy |
8,342
+7,965
| +2,113% | +$2.12M | 0.11% | 170 |
|
|
2020
Q1 | $103K | Buy |
377
+14
| +4% | +$3.81K | 0.01% | 562 |
|
|
2019
Q4 | $95K | Buy |
363
+183
| +102% | +$50.4K | 0.01% | 614 |
|
|
2019
Q3 | $48K | Buy |
+180
| New | +$49.3K | ﹤0.01% | 681 |
|
|
2017
Q1 | – | Sell |
-147
| Closed | -$21K | – | 639 |
|
|
2016
Q4 | $21K | Buy |
147
+31
| +27% | +$4.15K | ﹤0.01% | 592 |
|
|
2016
Q3 | $14K | Buy |
116
+46
| +66% | +$5.94K | ﹤0.01% | 741 |
|
|
2016
Q2 | $9K | Buy |
70
+23
| +49% | +$3.15K | ﹤0.01% | 726 |
|
|
2016
Q1 | $6K | Sell |
47
-1
| -2% | -$134 | ﹤0.01% | 630 |
|
|
2015
Q4 | $7K | Buy |
+48
| New | +$6.61K | ﹤0.01% | 620 |
|
Other funds holding ELV
Penserra Capital Management's ELV Position: Q2 2026 in Review
Penserra Capital Management held its Elevance Health (ELV) position steady in Q2 2026 at 18 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #943.
Penserra Capital Management first reported a position in ELV in Q4 2015 and has held it in 33 quarters since. The position peaked at $2.19M in Q2 2020. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Penserra Capital Management held 18 shares of Elevance Health worth $6K as of Q2 2026.
- Penserra Capital Management left its Elevance Health share count unchanged in Q2 2026.
- Elevance Health made up ﹤0.01% of Penserra Capital Management's portfolio in Q2 2026, its #943 holding.
- Penserra Capital Management first reported a position in Elevance Health in Q4 2015 and has held it in 33 quarters since.
- Penserra Capital Management's Elevance Health position peaked at $2.19M in Q2 2020.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Penserra Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.